3-deoxyglucosone has been researched along with Prediabetes in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Cai, J; Huang, F; Jiang, G; Liang, G; Song, X; Xu, H; Yin, M; Zhang, L; Zhou, L | 1 |
Freund, J; Hellwig, A; Hellwig, M; Henle, T; Herder, C; Hoffmann, B; Krämer, U; Luckhaus, C; Peßler, A; Roden, M; Schikowski, T; Schulte, T; Sugiri, D; Teichert, T; Vierkötter, A; Vossoughi, M | 1 |
Jiang, G; Liang, G; Song, X; Wang, F; Xu, H; Zhang, L; Zhou, L | 1 |
3 other study(ies) available for 3-deoxyglucosone and Prediabetes
Article | Year |
---|---|
Alteration of Intestinal Microbiota in 3-Deoxyglucosone-Induced Prediabetic Rats.
Topics: Administration, Oral; Animals; Deoxyglucose; Gastrointestinal Microbiome; Glucagon-Like Peptide 2; Glucose Tolerance Test; Lipopolysaccharides; Male; Prediabetic State; Rats, Sprague-Dawley; RNA, Ribosomal, 16S | 2020 |
Association between Advanced Glycation End Products and Impaired Fasting Glucose: Results from the SALIA Study.
Topics: Aged; Biomarkers; Blood Glucose; Chromatography, Liquid; Cross-Sectional Studies; Deoxyglucose; Fasting; Female; Glucose; Glycation End Products, Advanced; Humans; Inflammation; Insulin; Insulin Resistance; Pilot Projects; Prediabetic State; Tandem Mass Spectrometry | 2015 |
Acute Reduction of Incretin Effect and Glucose Intolerance in Rats by Single Intragastric Administration of 3-deoxyglucosone.
Topics: Animals; Cyclic AMP; Deoxyglucose; Glucagon; Glucagon-Like Peptide 1; Glucose Intolerance; Incretins; Insulin; Male; Mice; Prediabetic State; Rats | 2017 |